(Q42489607)

1 November 2017

title

Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

1 November 2017

main subject

1 reference

1 reference

A Vidal-Puig

1

1 reference

1 November 2017

M Muñoz-Torres

2

1 reference

1 November 2017

C Garcia-Calvente

3

1 reference

1 November 2017

E Jodar-Gimeno

4

1 reference

1 November 2017

P Lardelli

5

1 reference

1 November 2017

M E Ruiz-Requena

6

1 reference

1 November 2017

F Escobar-Jiménez

7

1 reference

1 November 2017

publication date

1 September 1994

1 reference

Journal of Endocrinological Investigation

1 November 2017

published in

1 reference

1 November 2017

volume

17

1 reference

1 November 2017

issue

8

1 reference

1 November 2017

page(s)

647-652

1 reference

Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Ketoconazole therapy for women with acne and/or hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Ketoconazole reverses hyperandrogenism in a patient with insulin resistance and acanthosis nigricans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Influence of food on the pharmacokinetics of ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Clinical pharmacokinetics of ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Suppression of Circulating Δ4-Androstenedione and Dehydroepiandrosterone Sulfate during Oral Glucose Tolerance Test in Normal Females*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

The gonadotropic function of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

On the paradox of insulin-induced hyperandrogenism in insulin-resistant states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Dehydroepiandrosterone sulfate and other possible influencing factors that modulate sex hormone-binding globulin levels in the hirsute patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349680

Defects in beta-cell function in functional ovarian hyperandrogenism

21 January 2018

1 reference

12 December 2020

Hormonal and clinical effects of ketoconazole in hirsute women

1 reference

12 December 2020

Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion.

1 reference

12 December 2020

Insulin as an effector of human ovarian and adrenal steroid metabolism.

1 reference

12 December 2020

Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency

1 reference

12 December 2020

Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women

1 reference

12 December 2020

Effects of ketoconazole in hirsute women

1 reference

12 December 2020

Persistence of hyperinsulinemia in polycystic ovary syndrome after ovarian suppression by gonadotropin-releasing hormone agonist

1 reference

12 December 2020

The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.

1 reference

12 December 2020

Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome

1 reference

12 December 2020

Hyperinsulinemia and hyperandrogenemia: in vivo androgen response to insulin infusion.

1 reference

12 December 2020

[New trends in the definition and diagnostic criteria of polycystic ovary syndrome]

1 reference

12 December 2020

Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome

1 reference

12 December 2020

The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism

1 reference

12 December 2020

Androgen and insulin response to an oral glucose challenge in hyperandrogenic women.

1 reference

12 December 2020

Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect.

1 reference

12 December 2020

Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance?

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03349680

1 reference

Dimensions Publication ID

1 November 2017

1012929592

0 references

1 reference